Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
CNY 15.82
(0.76%)
CNY 15.82
(0.76%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11.65 Million CNY | 51.28% |
| 2022 | 7.7 Million CNY | -10.56% |
| 2021 | 8.61 Million CNY | 3.22% |
| 2020 | 8.34 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 8.3 Million CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 13 Million CNY | -81.46% |
| 2015 | 70.1 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 607.15 Thousand CNY | -15.09% |
| 2024 Q1 | 4.74 Million CNY | -59.27% |
| 2024 Q2 | 4.87 Million CNY | 2.79% |
| 2023 FY | 11.65 Million CNY | 51.28% |
| 2023 Q3 | 11.06 Million CNY | -5.91% |
| 2023 Q2 | 11.76 Million CNY | 61.19% |
| 2023 Q4 | 11.65 Million CNY | 5.29% |
| 2023 Q1 | 7.29 Million CNY | -5.26% |
| 2022 FY | 7.7 Million CNY | -10.56% |
| 2022 Q4 | 7.7 Million CNY | -0.12% |
| 2022 Q3 | 7.71 Million CNY | -3.26% |
| 2022 Q2 | 7.97 Million CNY | -6.18% |
| 2022 Q1 | 8.49 Million CNY | -1.34% |
| 2021 Q3 | 4.92 Million CNY | 0.68% |
| 2021 Q1 | 4.56 Million CNY | -45.31% |
| 2021 FY | 8.61 Million CNY | 3.22% |
| 2021 Q4 | 8.61 Million CNY | 75.03% |
| 2021 Q2 | 4.88 Million CNY | 7.11% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 8.34 Million CNY | 0.0% |
| 2020 Q4 | 8.34 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q4 | 8.3 Million CNY | 0.0% |
| 2018 FY | 8.3 Million CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 FY | 13 Million CNY | -81.46% |
| 2015 FY | 70.1 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Lifecome Biochemistry Co.,Ltd. | 962.72 Million CNY | 98.79% |
| Chengdu Kanghua Biological Products Co., Ltd. | 194.75 Million CNY | 94.016% |
| NanHua Bio-medicine Co., Ltd | 44.27 Million CNY | 73.681% |
| Shandong Sito Bio-technology Co., Ltd. | 791.58 Million CNY | 98.528% |
| Porton Pharma Solutions Ltd. | 2.2 Billion CNY | 99.473% |
| Zhejiang Wecome Pharmaceutical Company Limited | 435.24 Million CNY | 97.323% |
| Guangdong VTR Bio-Tech Co., Ltd. | 128.24 Million CNY | 90.913% |